Mainstream NewsVaccine News

Regeneron’s COVID-19 treatment gets emergency approval from FDA

Regeneron’s COVID-19 treatment gets emergency approval from
FDA 1

The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Regeneron’s drug is a combination of two monoclonal antibodies. A similar drug developed by Eli Lilly & Co. gained FDA emergency clearance earlier this month.

However the Regeneron treatment may not be immediately widely available: the company has said it will have just 80,000 doses by the end of November.

Read the Full Article

Mainstream News, Vaccine News

Prepare Now Before its too Late

Discover where products are available & compare prices

Protesters in Guatemala Set Fire to Congress Building Over Spending Cuts
Kyle Rittenhouse, 17-year-old charged with fatally shooting 2 people in Kenosha protests, poses with ‘Silver Spoons’ actor after posting $2 million bail

You might also like
Menu